Lifestyle

New Delhi, May 28 (IANS) India’s contract development and manufacturing organisation (CDMO) sector is seeing a rapid realignment of hiring toward AI‑enabled capabilities, with AI‑linked skill demand up 178 per cent over the past two years, a report said on Thursday.

The report from HR solutions provider CIEL HR said the overall sectoral hiring rose 52 per cent from 2023 to 2025, while AI‑linked demand climbed from 6.2 per cent to 17.2 per cent in 2025.

The technology and digital roles showed the highest AI demand at nearly 38 per cent. Demand for AI-led skills is expanding beyond traditional technology roles into core functions such as research and development, quality and analytics.

Overall hiring saw the momentum shifting from manufacturing to capability-intensive roles amid sustained capacity expansion and rising complexity in outsourced pharmaceutical programs.

The report said that manufacturing and operations remained the largest single segment with 1,820 roles in 2025. However, these functions showed the slowest growth among role families at about 8 per cent year‑on‑year.

Hiring momentum is increasingly shifting away from labour intensity toward automation, planning accuracy and quality predictability.

The report flagged a widening execution gap between demand and available talent, particularly in high-value scientific roles.

While demand for AI skills in research and development roles has gone up to 24 per cent, the current supply of AI-skilled talent in these functions remains below 1 per cent, creating a significant execution constraint.

"The CDMO sector is entering a phase where competitive advantage will be the ability to integrate intelligence into every layer of operations. AI is becoming central to how research is accelerated, manufacturing is optimised and client commitments are delivered,” said Aditya Narayana Mishra, MD and CEO, CIEL HR.

The report noted that out of nearly 1,44,000 manufacturing professionals, only about 0.8 per cent are AI‑skilled. In commercial roles with nearly 1,19,000 professionals, nearly 0.1 per cent have AI capability. Data and analytics roles showed roughly 15 per cent AI skill penetration.

—IANS

aar/ag

New Delhi, May 28 (IANS) India has dispatched emergency pharmaceutical supplies as part of efforts to contain the Bundibugyo Ebola outbreak in the Democratic Republic of Congo, according to the Africa Centres for Disease Control and Prevention (Africa CDC).

The Ethiopia‑headquartered Africa CDC said in a social media post that the consignment, donated by the Government of India, was received in Uganda by its Eastern Africa Regional Coordinating Centre and will be deployed to affected communities in eastern DR Congo.

The supplies comprise essential diagnostics, therapeutics, infection prevention and control materials, and case management support, the agency said.

“Africa CDC welcomes the arrival of emergency pharmaceutical supplies generously donated by the government and people of India to support the ongoing response to the Bundibugyo Ebola outbreak in the DRC,” the continental public health agency said.

It thanked India for its “continued support and commitment to protecting lives and advancing health security across the continent”.

WHO declared the ongoing Ebola situation in the region as a Public Health Emergency of International Concern on May 17.

Over 1,000 suspected infections and at least 220 deaths had been reported as of Tuesday, including seven confirmed cases in Uganda, though health agencies have warned the true scale may be higher.

The Bundibugyo strain, one of six known species of the Ebola virus, has caused periodic outbreaks since its identification in Uganda in 2007. The World Health Organization (WHO) has said there are currently no approved drugs or vaccines specifically for the Bundibugyo strain.

Ebola often turns into a fatal illness transmitted through direct contact with infected bodily fluids, contaminated materials or infected animals, with symptoms ranging from fever, vomiting, diarrhoea and, in severe cases, internal and external bleeding.

India has stepped up medical assistance to African countries in recent years, supplying medicines and vaccines particularly during public health emergencies such as the COVID‑19 pandemic.

—IANS

aar/ag

New Delhi, May 27 (IANS) India has witnessed a significant rise in public spending on primary healthcare over the last decade, with government expenditure increasing from Rs 0.5 lakh crore in 2013-14 to Rs 1.4 lakh crore in 2022-23, as per the latest National Health Accounts (NHA) estimates on Wednesday.

The NHA estimates, released annually, provide a time-series analysis of actual health expenditure incurred by the government, private sector and other sources.

The current estimates for 2022-23 mark the 10th edition in the series that began in 2013-14.

According to the report, the steady rise in healthcare spending highlights the government’s increasing focus on strengthening primary healthcare services and improving healthcare access across the country.

A key component of this effort has been the operationalisation of more than 1.8 lakh Ayushman Arogya Mandir (AAMs) across India.

These centres provide 12 comprehensive primary healthcare service packages covering reproductive and child healthcare, communicable and non-communicable diseases, mental health, palliative care, oral healthcare, ENT services and emergency care.

The centres also offer free medicines, diagnostic services, wellness sessions and teleconsultation facilities.

To strengthen healthcare delivery further, the government has expanded the essential drug lists available at public healthcare facilities.

Under the revised framework, 106 drugs are available free of cost at SHC-AAMs, 172 at PHC-AAMs, 300 at community health centres, 318 at sub-district hospitals and 381 at district hospitals.

The range of free diagnostic services has also been expanded. Public health facilities now provide 14 diagnostic tests at SHC-AAMs, 63 at PHC-AAMs, 97 at community health centres, 111 at sub-district hospitals and 134 at district hospitals.

The government said mass awareness campaigns and proactive screening initiatives have helped bring healthcare services closer to people’s homes, promoting early detection and timely treatment of diseases.

The impact of these efforts is also reflected in findings from the National Sample Survey Office’s 80th round health survey.

According to the survey, healthcare demand has nearly doubled over the years, increasing from 6.8 per cent to 12.2 per cent in rural areas and from 9.1 per cent to 14.9 per cent in urban areas between 2017-18 and 2025.

--IANS

pk

Government health expenditure in India has increased to 1.43 per cent of Gross Domestic Product (GDP) in 2022–23, which is a steady rise in public investment in the healthcare sector, according to data released by the government on Wednesday.

According to the National Health Accounts (NHA) 2022–23 report, Government Health Expenditure (GHE) as a share of GDP has risen from 1.15 per cent in 2013–14 to 1.43 per cent in 2022–23.

Using the new GDP series with base year 2022–23, the share stands at 1.48 per cent, the Ministry of Health and Family Welfare said.

It noted that the increase reflects sustained efforts by the government to strengthen public healthcare infrastructure and expand access to services.

Moreover, GHE as a share of General Government Expenditure (GGE) has increased from 3.78 per cent to 4.89 per cent over the same period, indicating higher prioritisation of health in public spending.

In per capita terms, government health expenditure has nearly tripled from Rs 1,042 in 2013–14 to Rs 2,786 in 2022–23.

The ministry said the decade-long rise in public health spending has contributed to a reduction in out-of-pocket expenditure (OOPE) as a share of total health expenditure.

In addition, the share of government health expenditure in total health expenditure has increased from 28.6 per cent in 2013–14 to 43.7 per cent in 2022–23, underscoring a shift towards stronger public financing in healthcare.

The government highlighted improvements in social security expenditure and health insurance coverage, reflecting broader efforts towards financial protection and universal health coverage.

The National Health Accounts estimates are prepared by the National Health Accounts Technical Secretariat at the National Health Systems Resource Centre under the Ministry of Health and Family Welfare using the System of Health Accounts (2011) framework.

--IANS

ag/

New Delhi, May 27 (IANS) The Ministry of Ayush on Wednesday said it conducted a high-level review meeting and consultative discussions on the development of the International Classification of Health Interventions (ICHI) and National Health Intervention Codes (NHIC) for Ayurveda, Siddha and Unani (ASU) systems of medicine on May 25 and 26 in online mode.

The initiative follows the landmark Memorandum of Understanding (MoU) and Donor Agreement signed between the Ministry of Ayush and the World Health Organisation (WHO).

The objective is to create a globally standardised and scientifically robust coding vocabulary for ASU clinical interventions that can support cross-border data exchange, clinical research and interoperability in global healthcare systems, including insurance integration.

The meeting was chaired by Vaidya Rajesh Kotecha, Secretary, Ministry of Ayush, who underlined the strategic importance of internationally aligned intervention classifications.

He said the initiative would help integrate traditional medicine systems into global healthcare frameworks, improve documentation practices and strengthen interoperability in digital health ecosystems.

The inaugural session began with welcome remarks by Dr. N. Srikanth, Deputy Director General of the Central Council for Research in Ayurvedic Sciences (CCRAS). Dr. Kavita Jain, Joint Secretary, Ministry of Ayush, highlighted the importance of standardised intervention terminology for strengthening evidence-based traditional medicine systems.

Representatives from the World Health Organization also participated in the discussions. Dr. Pawan Godatwar, Technical Officer at WHO South-East Asia Regional Office (SEARO), and Dr. Geetha Krishnan, Unit Head at GTMC Jamnagar, addressed the session and discussed the global relevance of standardized coding systems for traditional medicine.

Detailed technical presentations on the four-level hierarchical coding directories were delivered by the respective research councils.

Prof. Vaidya Rabinarayan Acharya, Director General of CCRAS, presented the Ayurveda coding framework (NHICA), while Prof. Dr. N. J. Muthukumar, Director General of CCRS, presented the Siddha intervention classification system (NHICS). Dr. N. Zaheer Ahmed, Director General of CCRUM, presented the Unani coding framework (NHICUM).

--IANS

pk

New Delhi, May 25 (IANS) Amid growing concerns over Ebola cases reported in parts of Africa, the Directorate General of Civil Aviation (DGCA) has issued a comprehensive Standard Operating Procedure (SOP) for airlines operating flights connected to the Democratic Republic of the Congo and Uganda, mandating enhanced health screening and precautionary measures for incoming passengers.

The aviation regulator said the SOP is aimed at strengthening India's preparedness against potential cross-border health risks and ensuring early detection of suspected Ebola cases among international travellers. Airlines have been directed to implement mandatory passenger health declarations and adhere to strict monitoring protocols for passengers arriving from the affected regions.

Under the new guidelines, airlines must ensure compliance with health screening requirements, including the identification of suspected cases, immediate isolation measures and coordination with airport health authorities. Carriers have also been instructed to facilitate segregated seating arrangements for passengers displaying symptoms or suspected of infection during transit to minimise the risk of transmission.

The DGCA has made it mandatory for passengers travelling from the Democratic Republic of the Congo and Uganda to complete health declaration forms before boarding. The measure is intended to help authorities identify potential risk cases at an early stage and enable timely medical intervention if required.

The SOP covers a wide range of international carriers operating routes from the Democratic Republic of the Congo, including Ethiopian Airlines, Kenya Airways, Air Tanzania, Egyptair, Qatar Airways, Uganda Airlines, Turkish Airlines, Emirates, Air France, Etihad Airways, Air India, IndiGo and Akasa Air.

For Uganda, the guidelines apply to airlines such as Uganda Airlines, Ethiopian Airlines, Air Arabia, Emirates, Flydubai, Kenya Airways, Qatar Airways, Egyptair, Air Tanzania, Air India, Salam Air, Druk Air, Turkish Airlines, IndiGo, Flynas, KLM and Etihad Airways.

The move comes as authorities remain vigilant over the spread of Ebola in certain African regions, with aviation and health agencies working together to strengthen surveillance measures at international entry points and prevent the importation of infectious diseases into the country.

--IANS

pk

New Delhi, May 25 (IANS) The Indian Council of Medical Research (ICMR) on Monday held India’s largest biomedical and technology transfer facilitation here and 41 public‑health technologies were transferred to industry partners, an official statement said.

The event marked the establishment of country’s first structured platforms dedicated to biomedical innovation showcasing and technology transfer under the ICMR Medical Innovation Patent Mitra initiative.

The initiative aims to translate indigenous biomedical research into accessible, real-world healthcare solutions through strong industry partnerships, the statement from Ministry of Health and Family Welfare said.

Technologies transferred from ICMR institutes and innovators to industry partners include advanced diagnostics, vaccines, medical devices and biomedical solutions addressing critical public health priorities.

Among the technologies transferred were glycoconjugate and recombinant vaccines for Typhoid and Paratyphoid, as well as diagnostic technologies for diseases such as Japanese Encephalitis, Tuberculosis and Mpox.

“This initiative marks a decisive step in connecting Indian science with industry, ensuring that innovations developed in our laboratories translate into technologies that strengthen public health and advance Viksit Bharat,” said Prataprao Ganpatrao Jadhav, Union MoS, Ayush and Health and Family Welfare.

"India is moving from being a consumer of health technologies to becoming a global source of affordable and innovative healthcare solutions, powered by institutions like ICMR and strong industry partnerships,” Jadhav added.

India has the scientific capability and innovation ecosystem to emerge as a global leader in health technologies, Dr Gobardhan Das, Member, NITI Aayog, said.

Medical Innovation Patent Mitra will play a crucial role in protecting intellectual property, enabling technology transfer and accelerating the journey of indigenous innovations from laboratories to society, Das added.

The ‘Indian Biomedical Patent Landscape Report’ and the ‘Technology Compendium’ were also released at the event to strengthen India’s biomedical innovation, intellectual property and technology transfer ecosystem.

The event also showcased over 100 technologies in diagnostics, therapeutics and medical devices developed by ICMR institutes, researchers and startups.

—IANS

aar/pk

New Delhi, May 25 (IANS) In a significant step to enhance and modernise cancer care services, including early and precise tumour detection, the Army Hospital (Research and Referral) in the national capital has commissioned a ring gantry-based Linear Accelerator.​

The state-of-the-art, ring-gantry-based Linear Accelerator machine was commissioned in the hospital's Department of Radiation Oncology on Monday, in the presence of Defence Secretary Shri Rajesh Kumar Singh.​

The advanced technology is set to strengthen cancer care services at the Army Hospital (R&R) and improve access to advanced radiotherapy for serving personnel, veterans, and their dependents. It is also expected to enhance in-house treatment capacity to handle the hospital's significant patient load.​

According to an official statement, this Linear Accelerator is capable of delivering modern radiotherapy techniques, including Volumetric Modulated Arc Therapy, Intensity-Modulated Radiation Therapy, Image-Guided Radiation Therapy, Stereotactic Body Radiation Therapy, and Stereotactic Radiosurgery.​

“It enables precise delivery of radiation to tumour sites while minimising exposure to surrounding normal tissues, thereby supporting improved treatment outcomes and patient care,” the statement further said.​

Also, the previous equipment used for screening and scanning tumours and other cancerous growths in patients has been decommissioned.​

The procurement of the Linear Accelerator within the Armed Forces Medical Services (AFMS) marks a substantial upgrade from the previous equipment and will soon be implemented across various medical hospitals run by the Armed Forces.​

“The induction marks a step towards modernisation of oncology services within AFMS. Other oncology centres under AFMS are also being upgraded in a phased manner,” said an official.​

The occasion, i.e., commissioning of ring-gantry-based Linear Accelerator machine at the R&R hospital, saw the presence of DG AFMS Surgeon Vice Admiral Arti Sarin, Commandant, Army Hospital (R&R), Lieutenant General Avinash Das, and other senior officials.​

--IANS​

mr/dan

​

New Delhi, May 24 (IANS) Orthopaedic experts on Sunday raised concerns over a sharp rise in hip arthritis and avascular necrosis (AVN) cases among younger and middle-aged Indians in the post-COVID period, warning that severe hip damage linked to steroid use during the pandemic is driving a surge in total hip replacement surgeries across the country.

Speaking at the 2nd Delhi HIP 360 Conference here, leading orthopaedic specialists said hospitals are witnessing a growing number of patients in their 30s and 40s suffering from advanced hip joint damage, stiffness, limping, and difficulty in walking.

The conference was organised by the Delhi Orthopaedic Association in association with the Indian Arthroplasty Association and brought together orthopaedic surgeons, arthroplasty specialists, fellows, and residents from across the country to discuss advancements in total hip arthroplasty, robotic-assisted surgeries, rehabilitation, and management of post-COVID hip complications.

Dr. L Tomar, Organising Chairman of DELHI HIP 360 and Director of the Department of Orthopaedics and Joint Replacement at Max Hospital, said doctors are observing nearly a 40 per cent rise in hip replacement surgeries among younger patients.

“Steroids played a life-saving role during the COVID pandemic, but indiscriminate or prolonged use in some patients has been associated with a rise in osteonecrosis and early degenerative changes in the hip joint. We are now seeing relatively younger patients coming with severe hip damage, collapse of the femoral head, and advanced arthritis requiring early hip replacement surgeries,” he said.

Dr. Karun Jain, Organising Secretary of the conference, said many patients ignore early signs such as groin pain and stiffness, often mistaking them for muscular discomfort.

“One of the biggest challenges with AVN is delayed diagnosis. By the time patients seek medical advice, the hip joint may already have undergone irreversible collapse. Awareness, timely MRI evaluation, and early intervention can help reduce disability,” he said.

Dr. Gaurav Govil said total hip replacement has become one of the most successful procedures in modern orthopaedics due to improvements in surgical planning, implants, and rehabilitation methods.

“With better implants, advanced surgical planning, and faster rehabilitation techniques, patients are able to return to normal life much earlier than before. However, the focus must remain on early diagnosis and evidence-based treatment to prevent avoidable disability,” he said.

--IANS

pk

Washington, May 23 (IANS) Tulsi Gabbard, the US Director of National Intelligence, on Friday resigned from her position, citing her husband's ill-health.

"I am deeply grateful for the trust President Trump placed in me and for the opportunity to lead Office of the Director of National Intelligence (ODNI) for the last year-and-a-half. Unfortunately, I must submit my resignation effective from June 30. My husband, Abraham, has recently been diagnosed with an extremely rare form of bone cancer. He faces major challenges in the coming weeks and months. At this time, I must step away from public service to be by his side and fully support him through this battle." Gabbard said in her resignation letter addressed to the US President Donald Trump.

She said that while significant progress has been made at the ODNI in advancing "uprecedented transparency and restoring integrity to the intelligence community", there is still important work to be done.

She noted that she is fully committed to ensuring a smooth and thorough transition over the coming weeks to avoid any disruptions for the US President and his team in leadership or momentum.

Gabbard praised her husband for his support through her deployment to East Africa on Joint Special Operations mission political campaigns and her service in the role of Director of National Intelligence.

"I cannot in good conscience ask him (my husband) to face this fight alone while I continue in this demanding time-consuming position," she elaborated on her decision to step aside as the US Director of National Intelligence.

Trump responded to Gabbard's resignation on social media platform Truth Social, saying, "Tulsi has done an incredible job, and we will miss her. Her highly respected Principal Deputy Director of National Intelligence, Aaron Lukas, will serve as Acting Director of National Intelligence."

"Her (Tulsi Gabbard's) wonderful husband, Abraham, has been recently diagnosed with a rare form of bone cancer, and she, rightfully, wants to be with him, bringing him back to good health as they currently fight a tough battle together. I have no doubt he will soon be better than ever," the US President said.

--IANS

ksk/khz